D-0866-2020 Class II Terminated
FDA drug recall D-0866-2020 was initiated by Lupin Pharmaceuticals Inc. on February 19, 2020 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specification; high out of specification results observed The recall status is terminated (terminated June 3, 2021). Affected quantity: 876 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- March 11, 2020
- Initiation Date
- February 19, 2020
- Termination Date
- June 3, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 876 bottles
Product Description
Desoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD
Reason for Recall
Failed Impurities/Degradation Specification; high out of specification results observed
Distribution Pattern
Product was distributed throughout the United States.
Code Information
K800475 exp. date May 2020 K800477 exp. date June 2020